News Focus
News Focus
icon url

tornado1

09/11/09 1:58 PM

#3087 RE: blimps #3074

Maybe Mr. Stern does not know that!! You should become his advisor for corporate financial transactions? As I see it, CS formulated a strategy for this Company in the last 22 months after a long period in which the company had no clue where to go commercially . Before he started I red no word about gel, topical wound plus all the other topical applications which hopefully will help to earn money soon. The medical part of the company developed a what all here believe is a great product and the company in my opinion made a very good choice to hire Mr. Stern to bring this product to the market. By the way that has been initiated by big investors who still trust Stern.

If you would take 1 hour to think about the progress the company made and all the initiatives that have been started (PHIL, Swiss/Israel testing, strategy for topical applications etc.) you would see that this management is really seeking the success. Whether or not the product will be successful we don't know yet but we will know better very soon after the first product is launched. It is still a venture! Right?

All the steps they did so far do not lead me to conclude that the management is only out for dilution and greediness. All the first class doctors and big investors would not accept this game. After taking the facts into consideration and trying to come up with a fair conclusion I trust this company and the steps they propose.

The company will not go bankrupt without uplisting but the development will be slower and growth opportunities might not be taken as quickly. And speed is sometimes very important as other examples in the history show. Think about Microsoft dominating the market not because they had the best product but because the were the fastest.

I vote yes to give the management one more tool to develop this product as fast as possible and bring it to market for the benefit of people who need it and all stakeholders. Being at a reputable stock exchange can be a catalyst for a company like OXBO. OTCBB is the wrong place for this company. The last few days demonstrated that again. A few just manipulate and play with the fear of less informed investors.

I am a shareholder since 2004 and was never that optimistic as now.
icon url

charlieydrums

09/11/09 4:24 PM

#3097 RE: blimps #3074

Blimps,

Do you honestly believe that management and other large shareholders like Vatea Fund would not have done their homework as to listing requirements? They would not be going through all the filings and other requirements for a reverse split if they didn't believe 100% that the company would qualify for listing on a major exchange.
icon url

retiredendof99

09/11/09 8:51 PM

#3104 RE: blimps #3074

Blimps - PLEASE! Such a bogus argument. Thre are dozens of biotech companies listed on the NASDAQ that are still in the developmental stage that are in the same boat as OXBO - no product as of yet - no revenues, etc, etc.... How did they get listed to begin with? A magic wand?